AbZ-Pharma GmbH

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 2
Shared contracts: 2 (multi-supplier framework agreements)
Period: 1 September 2026 – 1 October 2026

Its main clients

DAK-Gesundheit · 2 contracts

Where and what

Supplies · 2

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
1 May 2028 re-tender around November 2027	Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Enalapril (ohne 2,5 mg + 5 mg), ATC C09AA02 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) DAK-Gesundheit	ratiopharm GmbH 1 A Pharma GmbH AbZ-Pharma GmbH 6 bids received	€1

Contracts won

Date	Contract	Buyer	Amount
01/10/2026	Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Enalapril (ohne 2,5 mg + 5 mg), ATC C09AA02 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate)	DAK-Gesundheit	€1 shared by 3
01/09/2026	Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Rivaroxaban, ATC B01AF01 für die Zeit 01.04.2026 - 30.06.2026	DAK-Gesundheit	€1 shared by 16

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.